Inventor profile of:

Jonathan L. Sessler

City:

Austin, Texas

Country:

United States

Published Applications:

28

Last publication date:

2025-04-24

Top Assignees for applications by Jonathan L. Sessler

The entities that hold a legal rights for patent applications filed by inventor Sessler Jonathan L.:

Recent patent applications by Sessler Jonathan L.

Jonathan L. Sessler from Austin, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-04-24
US20250129118A1
Chemistry; metallurgy

MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE

#2 | 2025-01-30
US20250034158A1
Chemistry; metallurgy

TEXAPHYRIN DERIVATIVES FOR MANGANESE CHEMOTHERAPY, PHOTOACOUSTIC IMAGING, AND PHOTOTHERMAL THERAPY

#3 | 2023-09-28
US20230303503A1
Chemistry; metallurgy

CELL ACTIVATABLE IRON CHELATORS

#4 | 2023-06-01
US20230167154A1
Chemistry; metallurgy

Melanocortin 1 receptor ligands and methods of use

#5 | 2023-04-13
US20230113036A1
Human necessities

TEXAPHYRIN-PT(IV) CONJUGATES AND COMPOSITIONS FOR USE IN OVERCOMING PLATINUM RESISTANCE

#6 | 2023-03-09
US20230072446A1
Chemistry; metallurgy

LITHIUM SELECTIVE ORGANOGELS

#7 | 2022-10-27
US20220340601A1
Chemistry; metallurgy

FUNCTIONALIZED GOLD CARBENE NAPTHAQUINONE COMPLEXES FOR USE IN THE TREATMENT OF CANCER

#8 | 2022-09-01
US20220274956A1
Chemistry; metallurgy

Compounds for the selective solid-liquid extraction and liquid-liquid extraction of lithium chloride

#9 | 2020-07-09
US20200216473A1
Chemistry; metallurgy

Naphthoquinone containing gold carbene complexes and methods of uses thereof

#10 | 2020-04-30
US20200129626A1
Human necessities

Anticancer prodrug for overcoming drug resistance

#11 | 2020-03-05
US20200069698A1
Human necessities

Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance

#12 | 2020-01-02
US20200002376A1
Chemistry; metallurgy

Melanocortin 1 receptor ligands and methods of use

#13 | 2019-08-01
US20190231888A1
Human necessities

TEXAPHYRIN AND ANTITUMOR ANTIBIOTIC CONJUGATES

#14 | 2017-08-31
US20170246182A1
Human necessities

Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance

#15 | 2017-08-03
US20170218017A1
Chemistry; metallurgy

Melanocortin 1 receptor ligands and methods of use

#16 | 2015-03-26
US20150086501A1
Human necessities

Polymers functionalized with ion-specific recognition elements

#17 | 2014-04-24
US20140112873A1
Chemistry; metallurgy

Melanocortin 1 receptor ligands and methods of use

#18 | 2011-02-10
US20110034431A1
Chemistry; metallurgy

Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer

#19 | 2010-08-05
US20100197031A1
Human necessities

Functionalized expanded porphyrins

#20 | 2010-05-27
US20100129308A1
Human necessities

Polymers functionalized with ion-specific recognition elements

#21 | 2009-08-20
US20090209509A1
Chemistry; metallurgy

Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer

#22 | 2007-09-20
US20070219276A1
Chemistry; metallurgy

Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer

#23 | 2007-01-04
US20070004699A1
Human necessities

Methods and compositions for treating atheroma, tumors and other neoplastic tissues

#24 | 2006-12-28
US20060292072A1
Human necessities

Agents for neutron capture therapy

#25 | 2006-10-17
US9838998
-

Calixpyrroles

#26 | 2006-05-09
US9939514
-

Halogenated calixpyrroles and uses thereof

#27 | 2006-01-10
US10373949
-

Cyclo[n]pyrroles and methods thereto

#28 | 2005-03-24
US20050064388A1
Human necessities

Methods and compositions for treating atheroma, tumors and other neoplastic tissue

InventorID:

735937 ⎘